Boundless Diagnostics
Portland, US · Founded 2023 · Delaware corporation
BoundlessDx (Boundless Diagnostics) develops portable, handheld point-of-care diagnostic devices that deliver rapid results from small fluid samples for veterinary use. Its tests, including inflammation and multi-analyte panels for dogs, cats, and horses, serve animal health practitioners in the veterinary diagnostics market.
BiotechHardwareMedical Devices
Founders & leadership
JH
Joshua HaywardExecutive
KG
Kevin GrantExecutive
TM
Trevor MorinExecutive
Reported raises · per SEC filings
Form D private placements$1M disclosed across 1 round · 2026
▶$1MraisedJul 2026 · 2 investors · Other TechnologyRule 506(b)
▶$1MraisedJul 2026 · 2 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
- Joshua HaywardExecutive Officer, Director
- Kevin GrantExecutive Officer, Director
- Trevor MorinExecutive Officer
- Offering amount
- $5M
- Amount sold
- $1M
- Proceeds to insiders
- $1.6M
- First sale
- Jun 2026
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 5
by search overlapCareDx5 shared keywordsCareDx provides molecular diagnostic testing, workflow software, patient support, and pharmacy services for care teams working in transplant, cell therapy, and specialty oncology. Its products support rejection monitoring and complex care management in precision medicine.
NOWDiagnostics (NOWDx)5 shared keywordsNowDx develops and manufactures "Touch to Test" over-the-counter and point-of-care diagnostic tests that return results in minutes using a small sample of capillary blood or saliva. Its patented method performs immunological assays onsite in one step, aimed at expanding access to in-home diagnostic testing.
Pinkdx5 shared keywordsPinkDx is a diagnostics company developing tests, led by a leadership team spanning scientific, medical, and business functions.
Labcorp4 shared keywordsLabcorp provides clinical laboratory testing, diagnostics, and lab data services for patients, healthcare providers, and biopharma companies, including genetic health panels, oncology testing, and self-ordered lab tests. It also offers AI-powered tools such as a results-explaining consumer app, a diagnostic assistant integrated into EHRs, and a laboratory data analytics platform to support drug development and clinical research.
Signature Diagnostics4 shared keywordsSignatureDx develops noninvasive diagnostics using cell-free DNA (cfDNA) from liquid biopsy to identify "signatures" for early prediction and detection of disease. Its research focuses on women's reproductive and maternal health, including pregnancy complications, and organ health such as kidney/lung monitoring and transplant rejection.
Companies competing with Boundless Diagnostics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Boundless Diagnostics do?
- BoundlessDx (Boundless Diagnostics) develops portable, handheld point-of-care diagnostic devices that deliver rapid results from small fluid samples for veterinary use. Its tests, including inflammation and multi-analyte panels for dogs, cats, and horses, serve animal health practitioners in the veterinary diagnostics market.
- How much funding has Boundless Diagnostics raised?
- Boundless Diagnostics has disclosed $1M raised across 1 round.
- Where is Boundless Diagnostics headquartered?
- Boundless Diagnostics is headquartered in Portland, US.